Rigel Pharmaceuticals (RIGL) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.36% |
| Dec 31, 2025 | 167.62% |
| Sep 30, 2025 | 84.49% |
| Jun 30, 2025 | 103.96% |
| Mar 31, 2025 | 37.55% |
| Dec 31, 2024 | 58.81% |
| Sep 30, 2024 | 64.76% |
| Jun 30, 2024 | 12.94% |
| Mar 31, 2024 | -33.70% |
| Dec 31, 2023 | 20.11% |
| Sep 30, 2023 | -18.71% |
| Jun 30, 2023 | -18.89% |
| Mar 31, 2023 | 13.99% |
| Dec 31, 2022 | -76.58% |
| Sep 30, 2022 | 4.71% |
| Jun 30, 2022 | 12.94% |
| Mar 31, 2022 | -4.24% |
| Dec 31, 2021 | 2.64% |
| Sep 30, 2021 | 12.94% |
| Jun 30, 2021 | 11.81% |
| Mar 31, 2021 | 26.27% |
| Dec 31, 2020 | 4.71% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 8.97% |
| Mar 31, 2020 | 21.24% |
| Dec 31, 2019 | 16.74% |
| Sep 30, 2019 | 21.84% |
| Jun 30, 2019 | 16.18% |
| Mar 31, 2019 | 15.14% |
| Dec 31, 2018 | 16.05% |
| Sep 30, 2018 | 12.31% |
| Jun 30, 2018 | 9.25% |
| Mar 31, 2018 | 10.13% |
| Dec 31, 2017 | 9.71% |
| Sep 30, 2017 | 17.21% |
| Jun 30, 2017 | 14.49% |
| Mar 31, 2017 | 16.49% |
| Dec 31, 2016 | 15.44% |
| Sep 30, 2016 | 0.81% |
| Jun 30, 2016 | 16.52% |
| Mar 31, 2016 | 13.83% |
| Dec 31, 2015 | 15.76% |
| Sep 30, 2015 | -15.80% |
| Jun 30, 2015 | -18.20% |